DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Cell based assay are 32




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
 References
DrugRepV_1615Quinacrine Hydrochloride
NA
Malaria | Giardiasis | Cutaneous leishmaniasis | Management of malignant effusions
Ebola virus
Recombinant, infectious Ebola virus encoding green fluorescent protein
NA
Cell based assay
Decrease (50 %)
Investigational
26834994
DrugRepV_1616Pyronaridine tetraphosphate
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
Recombinant, infectious Ebola virus encoding green fluorescent protein
NA
Cell based assay
Decrease (50 %)
Approved
26834994
DrugRepV_1617Tilorone Dihydrochloride
NA
Viral infections
Ebola virus
Recombinant, infectious Ebola virus encoding green fluorescent protein
NA
Cell based assay
Decrease (50 %)
NA
26834994
DrugRepV_1618Chloroquine Diphosphate
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
Recombinant, infectious Ebola virus encoding green fluorescent protein
NA
Cell based assay
Decrease (50 %)
Approved
26834994
DrugRepV_5491Amodiaquine Dihydrochloride Dihydrate
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
NA
NA
Cell based assay
Decrease (50 %)
Approved, Investigational
31882748
DrugRepV_5492Amodiaquine Dihydrochloride Dihydrate
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
NA
NA
Cell based assay
Decrease (50 %)
Approved, Investigational
31882748
DrugRepV_5493Amodiaquine Dihydrochloride Dihydrate
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
NA
NA
Cell based assay
Decrease (50 %)
Approved, Investigational
31882748
DrugRepV_5494Artesunate
Antiparasitic products, Insectisides and Repellents
Malaria
Ebola virus
NA
NA
Cell based assay
Decrease (50 %)
Approved, Investigational
31882748
DrugRepV_5495Winthrop
NA
NA
Ebola virus
NA
NA
Cell based assay
Decrease (50 %)
NA
31882748
DrugRepV_5496Winthrop
NA
NA
Ebola virus
NA
NA
Cell based assay
Decrease (50 %)
NA
31882748
DrugRepV_5497Winthrop
NA
NA
Ebola virus
NA
NA
Cell based assay
Decrease (50 %)
NA
31882748
DrugRepV_5498N-Desethylamodiaquine hydrochloride
NA
NA
Ebola virus
NA
NA
Cell based assay
Decrease (50 %)
NA
31882748
DrugRepV_5499N-Desethylamodiaquine hydrochloride
NA
NA
Ebola virus
NA
NA
Cell based assay
Decrease (50 %)
NA
31882748
DrugRepV_5500N-Desethylamodiaquine hydrochloride
NA
NA
Ebola virus
NA
NA
Cell based assay
Decrease (50 %)
NA
31882748
DrugRepV_5501Dihydroartimesinin
NA
Malaria
Ebola virus
NA
NA
Cell based assay
Decrease (50 %)
Experimental, Investigational
31882748
DrugRepV_5502Dihydroartimesinin
NA
Malaria
Ebola virus
NA
NA
Cell based assay
Decrease (50 %)
Experimental, Investigational
31882748
DrugRepV_6196(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-acetamido-5-[(prop-1-en-2-yl)amino]pentanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]hexanamido]-N-[(1S)-4-carbamimidamido-1-carbamoylbutyl]hexanamide
NA
NA
Dengue virus
NA
Pathway
Cell based assay
Decrease (5.31 ± 0.06 Log PFU/ml)
NA
25823617
DrugRepV_6197(E)-N-[(E)-({4-[(E)-{[(diaminomethylidene)amino]imino}methyl]phenyl}methylidene)amino]ethanimidamide
NA
NA
Dengue virus
NA
Pathway
Cell based assay
Decrease (5.37 ± 0.15 Log PFU/ml)
NA
25823617
DrugRepV_6198(2S)-6-amino-N-[(1S)-4-carbamimidamido-1-[(5-carbamimidamido-1-oxopentan-2-yl)carbamoyl]butyl]-2-[(2S)-2-(phenylformamido)propanamido]hexanamide
NA
NA
Dengue virus
NA
Pathway
Cell based assay
Decrease (5.38 ± 0.10 Log PFU/ml)
NA
25823617
DrugRepV_61997-[(phenylamino)(pyridin-2-yl)methyl]quinolin-8-ol
NA
NA
Dengue virus
NA
Pathway
Cell based assay
Decrease (5.34 ± 0.15 Log PFU/ml)
NA
25823617
DrugRepV_62001,8-dihydroxy-4,5-dinitro-9,10-dihydroanthracene-9,10-dione
NA
NA
Dengue virus
NA
Pathway
Cell based assay
Decrease (50 %)
NA
25823617
DrugRepV_62014-carbamimidamidophenyl 4-carbamimidamidobenzoate
NA
NA
Dengue virus
NA
Pathway
Cell based assay
Decrease (5.30 ± 0.10 Log PFU/ml)
NA
25823617
DrugRepV_62024-nitrophenyl 4-carbamimidamidobenzoate
NA
NA
Dengue virus
NA
Pathway
Cell based assay
Decrease (5.41 ± 0.17 Log PFU/ml)
NA
25823617
DrugRepV_6203(2E)-2-cyano-3-(4-hydroxyphenyl)prop-2-enamide
NA
NA
Dengue virus
NA
Pathway
Cell based assay
Decrease (5.46 ± 0.15 Log PFU/ml)
NA
25823617
DrugRepV_62044-[2-(2,4-dinitrophenyl)diazen-1-yl]naphthalen-1-ol
NA
NA
Dengue virus
NA
Pathway
Cell based assay
Decrease (5.49 ± 0.26 Log PFU/ml)
NA
25823617
DrugRepV_62051-ethyl-2-[(1E)-3-[(2Z)-1-ethyl-1H,2H-naphtho[1,2-d][1,3]oxazol-2-ylidene]prop-1-en-1-yl]naphtho[1,2-d][1,3]oxazol-1-ium
NA
NA
Dengue virus
NA
Pathway
Cell based assay
Decrease (50 %)
NA
25823617
DrugRepV_6206(2S)-6-amino-2-[(2S)-5-carbamimidamido-2-(phenylformamido)pentanamido]-N-[(1R)-1-carbamoylpentyl]hexanamide
NA
NA
Dengue virus
NA
Pathway
Cell based assay
Decrease (5.35 ± 0.21 Log PFU/ml)
NA
25823617
DrugRepV_6207(4R,7S,10S,13S,16S,22R)-22-amino-10,16-bis(4-aminobutyl)-13-(3-carbamimidamidopropyl)-7-(hydroxymethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxylic acid
NA
NA
Dengue virus
NA
Pathway
Cell based assay
Decrease (5.46 ± 0.35 Log PFU/ml)
NA
25823617
DrugRepV_62081-[N-(2-ethylhexyl)carbamimidamido]-N-(6-{N-[N-(2-ethylhexyl)carbamimidoyl]carbamimidamido}hexyl)methanimidamide
NA
NA
Dengue virus
NA
Pathway
Cell based assay
Decrease (5.62 ± 0.20 Log PFU/ml)
NA
25823617
DrugRepV_6209(1R,2R,4S,5S,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6-[(2S)-butan-2-yl]-21,24-dihydroxy-12-{[(2R,4S,6S)-5-{[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-5,11,13,22-tetramethyl-3,7,19-trioxaspiro[oxane-2,6-tet
NA
NA
Dengue virus
NA
Pathway
Cell based assay
Decrease
NA
25823617
DrugRepV_6210(1R,2R,4S,5S,6S,8R,10E,13S,14E,16E,20R,21E,24S)-6-cyclohexyl-24-hydroxy-12-{[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-21-(hydroxyimino)-5,11,13,22-tetramethyl-3,7,19-trioxaspiro[oxane-2,6-tetracyclo[15.6.1.14,8.0
NA
NA
Dengue virus
NA
Pathway
Cell based assay
Decrease
NA
25823617
DrugRepV_7791Ferruginol
NA
NA
Severe acute respiratory syndrome coronavirus
NA
NA
Cell based assay
Decrease (50 %)
NA
17663539